Envestnet Asset Management
VNDA icon

Envestnet Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Envestnet Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,822
Closed -$83.9K – 4681
2025
Q3 		$83.9K Buy
16,822
+954
+6% +$4.42K ﹤0.01% 4446
2025
Q2 		$74.9K Sell
15,868
-496
-3% -$2.17K ﹤0.01% 4369
2025
Q1 		$75.1K Buy
+16,364
New +$76.3K ﹤0.01% 4266
2024
Q4 		– Sell
-25,496
Closed -$120K – 4408
2024
Q3 		$120K Buy
25,496
+1,409
+6% +$7.55K ﹤0.01% 4105
2024
Q2 		$136K Buy
+24,087
New +$124K ﹤0.01% 4015
2023
Q4 		– Sell
-25,933
Closed -$112K – 4176
2023
Q3 		$112K Buy
25,933
+4,977
+24% +$27.7K ﹤0.01% 3854
2023
Q2 		$138K Buy
20,956
+1,180
+6% +$7.56K ﹤0.01% 3788
2023
Q1 		$134K Buy
19,776
+1,932
+11% +$13.6K ﹤0.01% 3746
2022
Q4 		$132K Buy
17,844
+6,634
+59% +$64.6K ﹤0.01% 3760
2022
Q3 		$111K Buy
11,210
+1,146
+11% +$12.1K ﹤0.01% 3717
2022
Q2 		$110K Buy
+10,064
New +$104K ﹤0.01% 3747
2022
Q1 		– Sell
-10,698
Closed -$168K – 4071
2021
Q4 		$168K Buy
+10,698
New +$186K ﹤0.01% 3686
2020
Q1 		– Sell
-11,685
Closed -$192K – 3145
2019
Q4 		$192K Buy
11,685
+889
+8% +$13.4K ﹤0.01% 2931
2019
Q3 		$143K Buy
10,796
+444
+4% +$6.19K ﹤0.01% 2924
2019
Q2 		$146K Buy
10,352
+162
+2% +$2.58K ﹤0.01% 2924
2019
Q1 		$187K Buy
+10,190
New +$232K ﹤0.01% 2843

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Envestnet Asset Management's VNDA Position: Q4 2025 in Review

Envestnet Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2025, closing a stake of 16,822 shares — an estimated $83.9K sold.

Envestnet Asset Management first reported a position in VNDA in Q1 2019 and held it in 16 quarters. The position peaked at $192K in Q4 2019. 153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

  • Envestnet Asset Management reported no remaining Vanda Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 16,822 Vanda Pharmaceuticals shares in Q4 2025, an estimated $83.9K.
  • Envestnet Asset Management first reported a position in Vanda Pharmaceuticals in Q1 2019 and held it in 16 quarters.
  • Envestnet Asset Management's Vanda Pharmaceuticals position peaked at $192K in Q4 2019.
  • 153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Envestnet Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.